Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Current Assets (2016 - 2022)

Historic Current Assets for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $113.2 million.

  • Avadel Pharmaceuticals' Current Assets fell 4498.98% to $113.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $113.2 million, marking a year-over-year decrease of 4498.98%. This contributed to the annual value of $192.5 million for FY2021, which is 2693.6% down from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Current Assets stood at $113.2 million for Q3 2022, which was down 4498.98% from $125.7 million recorded in Q2 2022.
  • Avadel Pharmaceuticals' 5-year Current Assets high stood at $281.7 million for Q3 2020, and its period low was $82.4 million during Q4 2019.
  • Over the past 5 years, Avadel Pharmaceuticals' median Current Assets value was $160.7 million (recorded in 2022), while the average stood at $172.3 million.
  • In the last 5 years, Avadel Pharmaceuticals' Current Assets tumbled by 5583.34% in 2019 and then soared by 21980.34% in 2020.
  • Quarter analysis of 5 years shows Avadel Pharmaceuticals' Current Assets stood at $124.9 million in 2018, then crashed by 34.02% to $82.4 million in 2019, then soared by 219.8% to $263.5 million in 2020, then dropped by 26.94% to $192.5 million in 2021, then crashed by 41.18% to $113.2 million in 2022.
  • Its last three reported values are $113.2 million in Q3 2022, $125.7 million for Q2 2022, and $160.7 million during Q1 2022.